Table 1.
Demographic and baseline patient features for patients in the three primary imaging groups (efficacy population)
| Gadoxetic acid-enhanced MRI (n = 118) | ECCM-MRI(n = 112) | CE-CT(n = 112) | |
|---|---|---|---|
| Age (years)* | 62 (37–82) | 64 (33–87) | 63 (32–88) |
| Weight (kg)* | 73 (42–146) | 72 (37–108) | 71 (42–115) |
| Sex ratio (M : F) | 80 : 38 | 73 : 39 | 74 : 38 |
| Previous resection of liver segments | 3 | 0 | 1 |
| Underlying liver disease | |||
| Hepatic cirrhosis | 0 | 1 | 0 |
| Hepatic steatosis | 1 | 4 | 0 |
*
Values are mean (range). MRI, magnetic resonance imaging; ECCM, extracellular contrast medium; CE-CT, contrast-enhanced computed tomography.